{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:08:53Z","timestamp":1780092533977,"version":"3.54.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,24]]},"DOI":"10.7759\/cureus.44020","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T08:52:59Z","timestamp":1692867179000},"source":"Crossref","is-referenced-by-count":1,"title":["Multifocal Abscesses, Necrotizing Fasciitis, Iron Deficiency Anemia, and Hypophosphatemia Induced by Ferric Carboxymaltose Infusions: Report of a Case of Hereditary Hemorrhagic Telangiectasia"],"prefix":"10.7759","author":[{"given":"Luana A","family":"Trevise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa P","family":"Lopes Vieira Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hasselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna C","family":"Lammoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thatiany P","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilton","family":"Salles Rosa Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-62702-5.00013-5","article-title":"Hereditary hemorrhagic telangiectasia","author":"Chung MG","year":"2015","unstructured":"Chung MG. Hereditary hemorrhagic telangiectasia. Handbook of Clinical Neurology. Islam MP, Roach ES (ed): Elsevier, Amsterdam; 2015. 132:185-97. 10.1016\/B978-0-444-62702-5.00013-5"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175245","article-title":"Hereditary hemorrhagic telangiectasia: genetics, pathophysiology, diagnosis, and management","volume":"11","author":"Viteri-No\u00ebl A","year":"2022","unstructured":"Viteri-No\u00ebl A, Gonz\u00e1lez-Garc\u00eda A, Patier JL, et al.. Hereditary hemorrhagic telangiectasia: genetics, pathophysiology, diagnosis, and management. J Clin Med. 2022, 11:5245. 10.3390\/jcm11175245","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan ME","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, et al.. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020, 173:989-1001. 10.7326\/M20-1443","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin CL","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, et al.. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000, 91:66-7. 10.1002\/(sici)1096-8628(20000306)91:1&lt;66::aid-ajmg12&gt;3.0.co;2-p","journal-title":"Am J Med Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013181","article-title":"Pearls & oy-sters: cerebral abscess secondary to pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia","volume":"98","author":"Roberts JI","year":"2022","unstructured":"Roberts JI, Woodward K, Kirton A, Esser MJ. Pearls &amp; oy-sters: cerebral abscess secondary to pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia. Neurology. 2022, 98:292-5. 10.1212\/WNL.0000000000013181","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0850-2","article-title":"European Reference Network For Rare Vascular Diseases (VASCERN) outcome measures for hereditary haemorrhagic telangiectasia (HHT)","volume":"13","author":"Shovlin CL","year":"2018","unstructured":"Shovlin CL, Buscarini E, Kjeldsen AD, et al.. European Reference Network For Rare Vascular Diseases (VASCERN) outcome measures for hereditary haemorrhagic telangiectasia (HHT). Orphanet J Rare Dis. 2018, 13:136. 10.1186\/s13023-018-0850-2","journal-title":"Orphanet J Rare Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104370","article-title":"The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care","volume":"65","author":"Shovlin CL","year":"2022","unstructured":"Shovlin CL, Buscarini E, Sabb\u00e0 C, et al.. The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care. Eur J Med Genet. 2022, 65:104370. 10.1016\/j.ejmg.2021.104370","journal-title":"Eur J Med Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab852","article-title":"Risk factors for and effects of persistent and severe hypophosphatemia following ferric carboxymaltose","volume":"107","author":"Schaefer B","year":"2022","unstructured":"Schaefer B, Zoller H, Wolf M. Risk factors for and effects of persistent and severe hypophosphatemia following ferric carboxymaltose. J Clin Endocrinol Metab. 2022, 107:1009-19. 10.1210\/clinem\/dgab852","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer B","year":"2022","unstructured":"Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M, Zoller H. Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management. Bone. 2022, 154:116202. 10.1016\/j.bone.2021.116202","journal-title":"Bone"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1213554","article-title":"Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia","volume":"368","author":"Devlin HL","year":"2013","unstructured":"Devlin HL, Hosman AE, Shovlin CL. Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. N Engl J Med. 2013, 368:876-8. 10.1056\/NEJMc1213554","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01770-2","article-title":"Intravenous iron-induced hypophosphatemia: an emerging syndrome","volume":"38","author":"Glaspy JA","year":"2021","unstructured":"Glaspy JA, Wolf M, Strauss WE. Intravenous iron-induced hypophosphatemia: an emerging syndrome. Adv Ther. 2021, 38:3531-49. 10.1007\/s12325-021-01770-2","journal-title":"Adv Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2011.10.036","article-title":"Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation","volume":"114","author":"Mathis S","year":"2012","unstructured":"Mathis S, Dupuis-Girod S, Plauchu H, et al.. Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clin Neurol Neurosurg. 2012, 114:235-40. 10.1016\/j.clineuro.2011.10.036","journal-title":"Clin Neurol Neurosurg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3023-7","article-title":"Prevalence of hereditary hemorrhagic telangiectasia in patients operated for cerebral abscess: a retrospective cohort analysis","volume":"36","author":"Larsen L","year":"2017","unstructured":"Larsen L, Marker CR, Kjeldsen AD, Poulsen FR. Prevalence of hereditary hemorrhagic telangiectasia in patients operated for cerebral abscess: a retrospective cohort analysis. Eur J Clin Microbiol Infect Dis. 2017, 36:1975-80. 10.1007\/s10096-017-3023-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3182136d32","article-title":"Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis","volume":"13","author":"McDonald J","year":"2011","unstructured":"McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med. 2011, 13:607-16. 10.1097\/GIM.0b013e3182136d32","journal-title":"Genet Med"},{"key":"ref15","article-title":"Hereditary hemorrhagic telangiectasia","author":"McDonald J","year":"2001","unstructured":"McDonald J, Stevenson DA. Hereditary hemorrhagic telangiectasia. GeneReviews\r\n. Adam MP, Everman DB, Mirzaa GM, et al. (ed): University of Washington, Seattle, Seattle, WA; 2001."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12098","article-title":"Immunological abnormalities associated with hereditary haemorrhagic telangiectasia","volume":"274","author":"Guilhem A","year":"2013","unstructured":"Guilhem A, Malcus C, Clarivet B, Plauchu H, Dupuis-Girod S. Immunological abnormalities associated with hereditary haemorrhagic telangiectasia. J Intern Med. 2013, 274:351-62. 10.1111\/joim.12098","journal-title":"J Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari H","year":"2021","unstructured":"Al-Samkari H. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care. Blood. 2021, 137:888-95. 10.1182\/blood.2020008739","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325210","article-title":"British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults","volume":"70","author":"Snook J","year":"2021","unstructured":"Snook J, Bhala N, Beales IL, et al.. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. 2021, 70:2030-51. 10.1136\/gutjnl-2021-325210","journal-title":"Gut"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178072-multifocal-abscesses-necrotizing-fasciitis-iron-deficiency-anemia-and-hypophosphatemia-induced-by-ferric-carboxymaltose-infusions-report-of-a-case-of-hereditary-hemorrhagic-telangiectasia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:17Z","timestamp":1707508517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178072-multifocal-abscesses-necrotizing-fasciitis-iron-deficiency-anemia-and-hypophosphatemia-induced-by-ferric-carboxymaltose-infusions-report-of-a-case-of-hereditary-hemorrhagic-telangiectasia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.44020","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}